Loading...
Not a good buy right now for an impatient trader. Despite a small recent bounce, XPOF is still in a broader bearish trend (SMA200 > SMA20 > SMA5) with weak fundamentals (Q3’25 revenue down YoY and deeper losses) and a clear pattern of analyst price-target cuts tied to operational headwinds (studio closures). Options positioning is extremely call-skewed, but the absolute volume is tiny and IV is elevated, which makes the bullish read less reliable. I’d wait for a technical reclaim above ~$8.22 (R1) or a fresh proprietary buy signal before treating this as a buy.
Trend/structure: Bearish moving-average stack (SMA_200 > SMA_20 > SMA_5) signals the primary trend remains down. Price closed at 7.81, below the pivot (7.932), which keeps near-term control with sellers. Momentum: MACD histogram is negative (-0.066) but contracting, suggesting downside momentum is easing (not a confirmed reversal). RSI(6) ~51.6 is neutral—no strong edge. Levels: Immediate support S1 ~7.646 then S2 ~7.469. Resistance is pivot ~7.932, then R1 ~8.218 (key reclaim level), R2 ~8.395. Pattern-based odds: Similar-pattern model suggests modest upside probabilities (next day +0.81%, next week +1.7%, next month +8.53%), but this is fighting the bearish MA regime.
Intellectia Proprietary Trading Signals

Hedge funds are net buying (reported buying amount +342.65% QoQ), which can provide support.
Gross margin improved materially in Q3’25 (73.39%, +9.15% YoY), showing better unit economics.
One major bull on the Street (Guggenheim) maintains a Buy and views shares as undervalued, highlighting Club Pilates strength.
No positive news flow in the last week; no obvious near-term catalyst from the provided feed.
Operational headwinds cited by analysts (elevated studio closures risk; refinement mode) are driving estimate cuts.
Primary technical trend remains bearish (downtrend MA structure); price is below pivot and needs to reclaim ~$8.22 to improve the setup.
Financial performance deteriorated YoY in Q3’25 (revenue down, losses deeper), limiting appetite for chasing bounces.
Latest quarter: 2025/Q3. Revenue was 78.824M (-2.12% YoY). Net income was -6.225M (down -33.19% YoY, i.e., larger loss). EPS was -0.18 (down -37.93% YoY). The notable bright spot is gross margin at 73.39% (+9.15% YoY), but profitability and top-line growth are currently trending the wrong way.
Recent trend: Mostly price-target cuts and cautious stances.